Scientific Advisory Board

Ed Racht, MD
Dr. Racht is the medical director for the City of Austin/Travis County Emergency Medical Services System, a diverse group of providers and agencies. Dr. Racht has been involved in Emergency Medical Services for eighteen years since receiving his medical degree from Emory University and completing his residency at the Medical College of Virginia.  Before relocating to Texas, he was an Assistant Professor and Associate Chief of the Medicine Section of Emergency Medical Services at the Medical College of Virginia in Richmond. In 1999, Dr. Racht was name EMS Medical Director of the Year for the State of Texas and in 2000 was named Volunteer of the Year for Capital Area.

Daniel D. Von Hoff, MD, FACP
Dr. Von Hoff is currently senior investigator and head of Translational Research at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, clinical professor of Medicine at University of Arizona, and Member Arizona Cancer Center. Dr. Von Hoff is the past president of the American Association for Cancer Research, a fellow of the American College of Physicians, and a member and past board member of the American Society of Clinical Oncology.  He is a founder and board member of ILEXä Oncology, Inc. (ILXO, Nasdaq).  He is founder and the editor emeritus of Investigational New Drugs – The Journal of New Anticancer Agents; and editor-in-chief of Molecular Cancer Therapeutics.  He is also chief scientific officer for US Oncology, the largest community oncology research group in the world. 

John Kuhn, PharmD
Dr. Kuhn currently holds an endowed professorship with the UT Austin College of Pharmacy and The University of Texas Health Science Center at San Antonio, Texas.  He received his B.S. in pharmacy from UT Austin in 1972 and his graduate doctoral degree in pharmacy from UT Austin and the University of Texas Health Science Center at San Antonio in 1977.  Dr. Kuhn has served as a National Cancer Institute (NCI) Phase I Investigator for the last 20 years, studying the pharmacology of anticancer agents.  He currently serves as the pharmacology core director for the NCI designated San Antonio Cancer Institute and the North American Brain Tumor Consortium.  He is also a co-holder of a US patent for a new drug delivery device, the Osteoport.  

George C. Kramer, PhD
Dr. Kramer is currently a professor in the Departments of Anesthesiology and Physiology & Biophysics and the director of Resuscitation Research Laboratory at The University of Texas Medical Branch, Galveston, Texas.  Dr. Kramer also is a leading authority in intraosseous research.

Norman Rosenberg, DO
Mr. Rosenberg taught Pediatric Emergency Medicine at Wayne State University after working in the Children's Hospital of Michigan.  Most recently, Mr. Rosenberg has invented an intraosseous device.

James Potyka, MD
Dr. Potyka is currently president of Emergency Physicians Affiliates and Medical Director of Airlife, while serving as an ER.  In 1997, he won EMS Medical Director of the Year.  

Kyriacos A. Athanasiou, Ph.D.
Dr. Athanasiou is the Karl F. Hasselmann professor of bioengineering and director of the musculoskeletal bioengineering laboratory at Rice University. He is a member of the board of directors of the 3,000-member Biomedical Engineering Society and is also a BMES Fellow, a past-president of the society and a former chair of both its finance and membership committees. Dr. Athanasiou also serves as faculty adviser to Rice's student chapter of BMES and holds 22 patents and has published more than 250 scientific papers, book chapters, abstracts and conference proceedings. He earned his B.S. from New York Institute of Technology and his M.S., Ph.M. and Ph.D. from Columbia University.